Product Name | NebuSelect™ Recombinant Human Kremen-2, His-tag |
---|---|
Catalog Number | NBL-240849 |
Alias/Synonyms | Kremen-2; KRM2; KREMEN2; Kremen-2; Dickkopf receptor 2 |
Appearance | see COA |
Molecule Weight | Gly26-Ala364 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q8NCW0-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240849-100ug | 100ug | Inquire | Inquire | |
NBL-240849-1mg | 1mg | Inquire | Inquire | |
NBL-240849-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Kremen-2, His-tag
Catalog#:
NBL-240849
Description:
NebuSelect™ Recombinant Human Kremen-2, His-tag(Cat#NBL-240849) is expressed in HEK293 with His tag at the C-Terminus.It contains Gly26-Ala364.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 37.1 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
Kremen-2; KRM2; KREMEN2; Kremen-2; Dickkopf receptor 2
Target Information:
Kremen2 (Krm2) plays an important role in embryonic development, bone formation, and tumorigenesis as a crucial regulator of classical Wnt/β-catenin signaling pathway. Compared to para-cancerous tissues, Krm2 was significantly up-regulated in gastric cancer tissues and was positively correlated with the pathological grade of gastric cancer patients. Krm2 can be a potent candidate for designing of targeted therapy.
Amino Acid Sequence:
Gly26-Ala364
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.